Prevalence of HIV among adults aged 15 to 49 in South-East Asia (WHO region)
South-East Asia (WHO region): Prevalence of HIV among adults aged 15 to 49 was 0.2% in 2025. ▼ Falling
Latest (2025)
0.2%
Change on year
unchanged
Rank
5th
of 7 groups
All-time high
0.6%
in 2000
All-time low
0.2%
in 2022
Years of data
26
2000–2025
Prevalence of HIV among adults aged 15 to 49 in South-East Asia (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, prevalence of hiv among adults aged 15 to 49 in South-East Asia (WHO region) stood at 0.2%. That is the lowest value across all 26 years on record.
The figure is down 33.3% over ten years.
Over the whole period, prevalence of hiv among adults aged 15 to 49 in South-East Asia (WHO region) peaked at 0.6% in 2000 and was at its lowest, 0.2%, in 2022.
The long-run direction has been consistently falling across the 26 years of available data.
Prevalence of HIV among adults aged 15 to 49 in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.6% | — |
| 2001 | 0.6% | +0.0% |
| 2002 | 0.6% | +0.0% |
| 2003 | 0.6% | +0.0% |
| 2004 | 0.5% | -16.7% |
| 2005 | 0.5% | +0.0% |
| 2006 | 0.5% | +0.0% |
| 2007 | 0.4% | -20.0% |
| 2008 | 0.4% | +0.0% |
| 2009 | 0.4% | +0.0% |
| 2010 | 0.4% | +0.0% |
| 2011 | 0.4% | +0.0% |
| 2012 | 0.4% | +0.0% |
| 2013 | 0.3% | -25.0% |
| 2014 | 0.3% | +0.0% |
| 2015 | 0.3% | +0.0% |
| 2016 | 0.3% | +0.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.3% | +0.0% |
| 2019 | 0.3% | +0.0% |
| 2020 | 0.3% | +0.0% |
| 2021 | 0.3% | +0.0% |
| 2022 | 0.2% | -33.3% |
| 2023 | 0.2% | +0.0% |
| 2024 | 0.2% | +0.0% |
| 2025 | 0.2% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.5% | 0.4% | 0.6% | 10 |
| 2010s | 0.3% | 0.3% | 0.4% | 10 |
| 2020s | 0.2% | 0.2% | 0.3% | 6 |
Countries ranked near South-East Asia (WHO region)
More health data for South-East Asia (WHO region)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is prevalence of hiv among adults aged 15 to 49 in South-East Asia (WHO region)?
- Prevalence of hiv among adults aged 15 to 49 in South-East Asia (WHO region) was 0.2% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of hiv among adults aged 15 to 49 recorded in South-East Asia (WHO region)?
- The highest recorded value was 0.6% in 2000.
- What is the lowest prevalence of hiv among adults aged 15 to 49 recorded in South-East Asia (WHO region)?
- The lowest recorded value was 0.2% in 2022.
- How does South-East Asia (WHO region) rank for prevalence of hiv among adults aged 15 to 49?
- South-East Asia (WHO region) ranks 5th out of 7 groups with data for 2025.
- Is prevalence of hiv among adults aged 15 to 49 rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is down 33.3%. The long-run trend across the full record is falling.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of HIV among adults aged 15 to 49 (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).